Suppr超能文献

向个体研究参与者报告基因研究结果:瑞士个性化健康网络指南

Reporting Genetic Findings to Individual Research Participants: Guidelines From the Swiss Personalized Health Network.

作者信息

Blasimme Alessandro, Brall Caroline, Vayena Effy

机构信息

Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland.

Ethical, Legal, and Social Implications (ELSI) Advisory Group, Swiss Personalized Health Network (SPHN), Bern, Switzerland.

出版信息

Front Genet. 2020 Dec 11;11:585820. doi: 10.3389/fgene.2020.585820. eCollection 2020.

Abstract

In 2017 the Swiss federal government established the Swiss Personalized Health Network (SPHN), a nationally coordinated data infrastructure for genetic research. The SPHN advisory group on Ethical, Legal, and Social Implications (ELSI) was tasked with the creation of a recommendation to ensure ethically responsible reporting of genetic research findings to research participants in SPHN-funded studies. Following consultations with expert stakeholders, including geneticists, pediatricians, sociologists, university hospitals directors, patient representatives, consumer protection associations, and insurers, the ELSI advisory group issued its recommendation on "Reporting actionable genetic findings to research participants" in May 2020. In this paper we outline the development of this recommendation and the provisions it contains. In particular, we discuss some of its key features, namely: (1) that participation in SPHN-funded studies as a research subject is conditional to accepting that medically relevant genetic research findings will be reported; (2) that a Multidisciplinary Expert Panel (MEP) should be created to support researchers' decision-making processes about reporting individual genetic research findings; (3) that such Multidisciplinary Expert Panel will make case-by-case decisions about whether to allow reporting of genetic findings, instead of relying on a pre-defined list of medically relevant variants; (4) that research participants shall be informed of the need to disclose genetic mutations when applying for private insurance, which may influence individual decisions about participation in research. By providing an account of the procedural background and considerations leading to the SPHN recommendation on "Reporting actionable genetic findings to research participants," we seek to promote a better understanding of the proposed guidance, as well as to contribute to the global dialog on the reporting of genetic research findings.

摘要

2017年,瑞士联邦政府设立了瑞士个性化健康网络(SPHN),这是一个全国范围内协调的基因研究数据基础设施。SPHN伦理、法律和社会影响(ELSI)咨询小组的任务是制定一项建议,以确保在SPHN资助的研究中,以符合伦理的方式向研究参与者报告基因研究结果。在与包括遗传学家、儿科医生、社会学家、大学医院院长、患者代表、消费者保护协会和保险公司在内的专家利益相关者进行磋商后,ELSI咨询小组于2020年5月发布了关于“向研究参与者报告可操作的基因研究结果”的建议。在本文中,我们概述了该建议的制定过程及其包含的条款。特别是,我们讨论了它的一些关键特征,即:(1)作为研究对象参与SPHN资助的研究的条件是接受将报告与医学相关的基因研究结果;(2)应设立一个多学科专家小组(MEP),以支持研究人员关于报告个体基因研究结果的决策过程;(3)这样的多学科专家小组将逐案决定是否允许报告基因研究结果,而不是依赖于预先定义的与医学相关的变异列表;(4)研究参与者在申请私人保险时应被告知披露基因突变的必要性,这可能会影响个人参与研究的决定。通过介绍导致SPHN关于“向研究参与者报告可操作的基因研究结果”建议的程序背景和考虑因素,我们旨在促进对拟议指南的更好理解,并为关于基因研究结果报告的全球对话做出贡献。

相似文献

2
SPHN - The Swiss Personalized Health Network Initiative.瑞士个性化健康网络倡议
Stud Health Technol Inform. 2020 Jun 16;270:1156-1160. doi: 10.3233/SHTI200344.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

本文引用的文献

2
Future-proofing biobanks' governance.为生物银行的治理做好前瞻性规划。
Eur J Hum Genet. 2020 Aug;28(8):989-996. doi: 10.1038/s41431-020-0646-4. Epub 2020 May 18.
7
Health Research with Big Data: Time for Systemic Oversight.大数据健康研究:进行系统性监督的时候了。
J Law Med Ethics. 2018 Mar;46(1):119-129. doi: 10.1177/1073110518766026. Epub 2018 Mar 27.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验